Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shlomo Almog

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Thrombosis and Haemostasis|February 24, 2006
Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarinManuela Vecsler, Ronen Loebstein, Shlomo Almog, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9Ronen Loebstein, Manuela Vecsler, Daniel Kurnik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan eliminationShlomo Almog, Daniel Kurnik, Avichai Shimoni, et al.
European Journal of Pain (London, England)|May 24, 2020
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trialShlomo Almog, Judith Aharon-Peretz, Simon Vulfsons, et al.
The Israel Medical Association Journal : IMAJ|December 17, 2008
Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factorsRonen Loebstein, Rafae Mahagna, Yasmin Maor, et al.
Blood|November 18, 2006
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistanceRonen Loebstein, Ilana Dvoskin, Hillel Halkin, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Thrombosis and Haemostasis|February 24, 2006
Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarinManuela Vecsler, Ronen Loebstein, Shlomo Almog, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9Ronen Loebstein, Manuela Vecsler, Daniel Kurnik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan eliminationShlomo Almog, Daniel Kurnik, Avichai Shimoni, et al.
European Journal of Pain (London, England)|May 24, 2020
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trialShlomo Almog, Judith Aharon-Peretz, Simon Vulfsons, et al.
The Israel Medical Association Journal : IMAJ|December 17, 2008
Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factorsRonen Loebstein, Rafae Mahagna, Yasmin Maor, et al.
Blood|November 18, 2006
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistanceRonen Loebstein, Ilana Dvoskin, Hillel Halkin, et al.
Pageof 2